These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 576519)

  • 1. Kinetic aspects of the interaction of blood clotting enzymes. VII. The relation between clotting time and prothrombin concentration.
    Hemker HC; Vermeer C; Govers-Riemslag J
    Thromb Haemost; 1977 Feb; 37(1):81-5. PubMed ID: 576519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic aspects of the interaction of blood-clotting enzymes. II. The relation between clotting time and plasma concentration in prothrombin-time estimations.
    Hemker HC; Siepel T; Altman R; Loeliger EA
    Thromb Diath Haemorrh; 1967 May; 17(3-4):349-57. PubMed ID: 5589294
    [No Abstract]   [Full Text] [Related]  

  • 3. Kinetic aspects of the interaction of blood clotting enzymes. IV. Kinetics of competitive inhibition in clotting tests.
    Hemker HC; Hemker PW
    Thromb Diath Haemorrh; 1968 Jul; 19(3):364-7. PubMed ID: 5708124
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of clotting inhibitive chronic dose of phenprocoumon on the prothrombin level and various enzymes of the rat].
    Stresemann E; Ast D
    Arzneimittelforschung; 1971 Jan; 21(1):145. PubMed ID: 5108379
    [No Abstract]   [Full Text] [Related]  

  • 5. Kinetic aspects of the interaction of blood clotting enzymes. 3. Demonstration of an inhibitor of prothrombin conversion in vitamin K deficiency.
    Hemker HC; Veltkamp JJ; Loeliger EA
    Thromb Diath Haemorrh; 1968 Jul; 19(3):346-63. PubMed ID: 4179187
    [No Abstract]   [Full Text] [Related]  

  • 6. Blood coagulation and fibrinolysis in a random sample of 788 men 54 years old. I. Correlations between the variables of clotting and fibrinolysis.
    Korsan-Bengtsen K; Wilhelmsen L; Tibblin G
    Thromb Diath Haemorrh; 1972 Aug; 28(1):89-98. PubMed ID: 5074993
    [No Abstract]   [Full Text] [Related]  

  • 7. [Laboratory methods for the estimation of plasma clotting factors. Phase 2].
    Kagami M
    Rinsho Byori; 1969; 16():Suppl 16:85-92. PubMed ID: 5391589
    [No Abstract]   [Full Text] [Related]  

  • 8. Blood coagulation. Role of Hageman protein (F-XII) and autoprothrombin II (F-IX?) in the activation of autoprothrombin 3 (F-X).
    Seegers WH; Grammens GL; McCoy LE
    Thromb Diath Haemorrh; 1970 Dec; 24(3):345-51. PubMed ID: 5533980
    [No Abstract]   [Full Text] [Related]  

  • 9. Blood clotting changes in guinea pigs with a heterologous intracranial neoplasm.
    Hurt JP; Odom MH; Perlmutt L; Krigman MR
    Lab Invest; 1970 Aug; 23(2):179-83. PubMed ID: 4317572
    [No Abstract]   [Full Text] [Related]  

  • 10. Kinetic aspects of the interaction of blood clotting enzymes. VIII. The relation between clotting time and clotting velocity.
    Hemker HC; Kop J; Willems GM
    Thromb Haemost; 1979 Apr; 41(2):309-13. PubMed ID: 473114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothermia and blood coagulation: dissociation between enzyme activity and clotting factor levels.
    Reed RL; Bracey AW; Hudson JD; Miller TA; Fischer RP
    Circ Shock; 1990 Oct; 32(2):141-52. PubMed ID: 2253317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Routine tests as measures of the total intrinsic blood clotting potential. A comparison of whole blood clotting time (WBCT), recalcification time of citrated plasma (RTST), partial thromboplastin time (PTT), and activated partial thromboplastin time (APTT).
    Korsan-Bengtsen K
    Scand J Haematol; 1971; 8(5):359-68. PubMed ID: 4109186
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of some human clotting abnormalities with the clotting pattern of normal guinea pigs.
    Chenkin T; Weiner M
    Exp Med Surg; 1965; 23(4):398-405. PubMed ID: 5864746
    [No Abstract]   [Full Text] [Related]  

  • 14. Coagulation changes in isolated perfused lungs.
    Deysine M; Panossian A; Clarke RL; Cliffton EE; Veith FJ
    Vasc Dis; 1968 Jun; 5(2):70-7. PubMed ID: 5655303
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased activity of vitamin K-dependent clotting factors in human hyperlipoproteinaemia - association with cholesterol and triglyceride levels.
    Constantino M; Merskey C; Kudzma DJ; Zucker MB
    Thromb Haemost; 1977 Aug; 38(2):465-74. PubMed ID: 579489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some effects of purified autoprothrombin C in blood clotting.
    Müller-Berghaus G; Seegers WH
    Thromb Diath Haemorrh; 1966 Dec; 16(3):707-22. PubMed ID: 5996683
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibitor of blood clotting derived from prothrombin.
    Marciniak E; Murano G; Seegers WH
    Thromb Diath Haemorrh; 1967 Aug; 18(1-2):161-6. PubMed ID: 6071101
    [No Abstract]   [Full Text] [Related]  

  • 18. Mitigation of coagulation by removing clotting factors part 1: in vitro feasibility study.
    Parker JT; Beutler DS; Sukavaneshvar S; Jacobs N; Solen KA; Mohammad SF
    ASAIO J; 2007; 53(4):415-20. PubMed ID: 17667224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical use of a test for determination of coagulation factors II, X and VII].
    Cascino A; Cangiano C; Attili AF
    Minerva Med; 1975 Aug; 66(55):2743-9. PubMed ID: 1161171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of single and repeated hemodialises on the blood coagulation status].
    Albert FW; Kreiter H
    Munch Med Wochenschr; 1972 Nov; 114(44):1917-21. PubMed ID: 4678729
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.